SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.820
-0.130 (-6.67%)
At close: Feb 21, 2025, 4:00 PM
1.760
-0.060 (-3.30%)
After-hours: Feb 21, 2025, 4:57 PM EST
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $16.80 million as of February 21, 2025. Its market cap has decreased by -67.08% in one year.
Market Cap
16.80M
Enterprise Value
-9.08M
1-Year Change
-67.08%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $16.80M, a decrease of -87.15%. That is a compound annual growth rate of -39.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 16.80M | -52.03% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |